Prescient is an evidence-based decision-support partner to the pharmaceutical and biotech industries whose mission is to optimally shape new product, brand and mature product planning strategies.

Our diverse yet integrated skillsets and methodologies ensure our clients’ key decisions are objectively assessed from both a clinical and commercial perspective, resulting in differentiated products and offerings.

 

Shaping Decisions Driving Value

Our People

Prescient’s team consists of highly experienced executives who share our core values of thinking collaboratively, creatively and constructively. We effectively integrate different skills and perspectives into a single client-engagement team.

Our Approach

The format and scope of our engagements are customized to meet our clients’ needs and our ‘best-in-front’ team philosophy ensures access to the necessary levels of expertise and thinking.

Our Clients

We engage directly with a number of functions supporting new product, brand and mature product planning activities; to view a full list of these, please click the
link below.

Latest News

Open-source drug discovery

Study suggests new drug candidate could treat both type 2 diabetes and bone loss

Merck receives Breakthrough Therapy Designation from FDA and PRIME status from EMA for investigation …

FDA updates warnings for fluoroquinolone antibiotics

Male hormone reverses cell aging in clinical trial

Roche delivers continued growth in the first half of 2016

Combining new and old drugs improves survival for soft-tissue cancer patients

The European Stroke Organisation and Boehringer Ingelheim launch the "Angels Initiative"

Anti-tumor antibodies could counter atherosclerosis

Pfizer receives World Health Organization prequalification for multi-dose vial presentation of Preve …

Moderate exercise might be more effective at combatting pre-diabetes

Zika epidemic likely to end within 3 years

Amgen and Daiichi Sankyo announce agreement to commercialize biosimilars in Japan

Losing weight lowered levels of proteins associated with tumor growth

Boehringer Ingelheim and Lilly announce clinical trial collaboration in metastatic breast cancer

Pfizer bags option on oncolytic virus, partners up to advance through PhI

Biotech IPOs sink this summer–10 of last 12 are underwater

Celgene affirms Juno CAR-T deal as key to long-term growth

Editas signs genome-edited stem cell pact with GSK, Biogen biotech partner

EuroBiotech: More Articles of Note

Regulus hopes for quick turnaround on FDA hold on hep C drug

UPDATED: Q2 clear-out sees AstraZeneca dump gastric cancer, NASH PhIII studies

EuroBiotech Report: J&J-Genmab, Merck-ALK, uniQure, PhII misstep and Morphochem

UniQure yo-yos as data raise questions about its place in hem B gene therapy race

BioMarin up on positive gene therapy data in hemophilia A

After Pfizer's InnoPharma buyout, investors back team with $55M for next specialty pharma

GSK pays up to $230M on J&J deal for asthma antibody

Waksal's Kadmon IPO crumbles after raising $75M

Astellas boosts funding, involvement in updated Cytokinetics collab

TauRx misses primary endpoints in Alzheimer’s combo PhIII trial

UK's revamped Cancer Drugs Fund 'will not work'

Increased sales of multiple myeloma drug Revlimid boost Celgene's profits

B-MS ups earnings forecast on back of positive 2nd-qtr results

China's Fosun in $1.3 billion deal to buy 86% stake in Gland Pharma

Vivus goes to court to stop Hetero infringement of Stendra patents in USA

FTC settlement confirms conditions of Teva-Allergan deal

UCB continues to deliver steady growth, with net sales up 15%

AstraZeneca 2nd-qtr sales hit by loss of Crestor patent

Ipsen 1st-half sales up 9.5%, driven by Specialty Care unit

Jury out on TauRx’s claims of progress in Alzheimer’s

FDA approves Sanofi’s Adlyxin for adult type 2 diabetes patients

Cytokinetics and Astellas expanded ALS research pact that could lead to new treatment breakthroughs

Almirall and Sun Pharma in $50 million European license deal for psoriasis drug tildrakizumab

A Waltz with Taltz – dermatologists report early adoption of ixekizumab in psoriasis

Phase III data shows efficacy of CSL Behring's Afstyla in pediatric hemophilia A

Medical News Today: Alzheimer's drug shows promise for patients in phase III trial

Medical News Today: App trains healthcare professionals to detect early stage skin cancer

Medical News Today: What is a Hiatal Hernia?

Medical News Today: Just 1 hour of exercise offsets health risks of prolonged sitting

Medical News Today: ALS Ice Bucket Challenge fuels novel gene discovery

Medical News Today: Apollo astronauts more prone to cardiovascular problems

Medical News Today: Poison Oak: Identifying and Treating this Poisonous Plant Rash

Medical News Today: Just 1 minute of secondhand marijuana smoke impairs blood vessel function

Medical News Today: Resveratrol study offers new insight into Alzheimer's

Medical News Today: All You Need to Know About Flea Bites

Medical News Today: Ketone drink may help athletes unlock greater human metabolic potential

Medical News Today: E-cigarettes: Toxic emission level dependent on temperature, type, age of device

Medical News Today: Acetaminophen: Is it as safe as we think?

Medical News Today: Mono: What are the Early Signs and Symptoms?

Medical News Today: Transgender identity 'should not be classified as a mental disorder'

GSK bolsters asthma pipeline

Teva divests 79 drugs to clear Allergan deal

Investigation claims NHS impeding access to hep-c drugs

Dynamic and different L&D prospect for Pharma marketers and teams

Time is running out to enter Sales Manager of the Year 2016

GSK invests £275m in UK manufacturing

Nerve stimulation reduces impact of migraine

Top three therapy areas dominate pipelines

Boehringer stops Giotrif head and neck trials

CHMP nod for Allergan's IBS-D drug

Sanofi Pasteur MSD's four-strain flu vaccine approved

NICE approves Servier’s Lonsurf as third-line cancer therapy

Anti-malaria drug could help fight cancer

Shire’s pancreatic cancer drug gets EMA nod

Breakthrough status for Pfizer/Spark haemophilia gene therapy

More News